EFFECT OF RESVERATROL ON BLOOD BIOCHEMICAL PARAMETERS IN ALLOXAN-INDUCED DIABETIC RATS
Diabetes mellitus is a chronic metabolic disease characterized by an increase in blood glucose levels, leading to numerous
physiological and biochemical alterations. Significant deviations in hematological and biochemical parameters are observed during
diabetes. In recent years, the effect of resveratrol, a natural polyphenolic compound, on the pathogenesis of diabetes has been
extensively studied.
1. American Diabetes Association. (2023). *Diagnosis and classification of diabetes mellitus.* Diabetes Care, 46(Suppl
1):S19–S27.
2. DeFronzo, R. A. (2009). *From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2
diabetes mellitus.* Diabetes, 58(4), 773–795.
3. Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014). *Pathophysiology and treatment of type 2 diabetes: perspectives
on the past, present, and future.* Lancet, 383(9922), 1068–1083.
4. Forbes, J. M., & Cooper, M. E. (2013). *Mechanisms of diabetic complications.* Physiological Reviews, 93(1), 137–
188.
5. International Diabetes Federation. (2021). *IDF Diabetes Atlas* (10th ed.). Brussels, Belgium.
6. Saeedi, P., et al. (2019). *Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and
2045.* Diabetes Research and Clinical Practice, 157, 107843.
7. WHO. (2022). *Global report on diabetes.* Geneva: World Health Organization.
8. Evans, J. L., et al. (2002). *Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2
diabetes.* Endocrine Reviews, 23(5), 599–622.
9. Robertson, R. P. (2004). *Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta
cells in diabetes.* Journal of Biological Chemistry, 279(41), 42351–42354.
10. Bailey, C. J., & Day, C. (2004). *Metformin: its botanical background.* Practical Diabetes International, 21(3), 115–
117.
11. Nathan, D. M. (2015). *Diabetes: advances in diagnosis and treatment.* JAMA, 314(10), 1052–1062.
12. Ramkumar, K. M., et al. (2011). *Natural products and their anti-diabetic potential.* Planta Medica, 77(14), 1686–
1697.
13. Takaoka, M. (1940). *Resveratrol, a new phenolic compound from Veratrum grandiflorum.* Journal of the Chemical
Society of Japan, 61, 365–370.
14. Baur, J. A., & Sinclair, D. A. (2006). *Therapeutic potential of resveratrol: the in vivo evidence.* Nature Reviews
Drug Discovery, 5(6), 493–506.
15. Um, J. H., et al. (2010). *AMP-activated protein kinase–deficient mice are resistant to the metabolic effects of
resveratrol.* Diabetes, 59(3), 554–563.
16. Su, H. C., et al. (2020). *Resveratrol alleviates oxidative stress and improves insulin sensitivity in diabetic rats via
SIRT1/AMPK pathway.* Molecular Medicine Reports, 22(4), 2741–2749.
17. Szkudelski, T. (2006). *Resveratrol inhibits insulin secretion from rat pancreatic islets through a mechanism involving
nitric oxide and cyclic GMP.* British Journal of Pharmacology, 149(4), 431–435.
18. Захарова С.М. Медико-социальное обоснование первичной профилактики сахарного диабета типа 2:
автореферат дис. на соиск. учен.степ. доктора мед. наук. 2005, - 48 с.
Copyright (c) 2025 «ACTA NUUz»
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
.jpg)
1.png)
